PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway
Abstract Background Alzheimer’s disease (AD), the most common form of dementia, is caused by the degeneration of the central nervous system (CNS). A previous study reported that signal transducer and activator of transcription 3 (STAT3) is activated during AD development; nonetheless, the related me...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c3b6354346f48fd8f7bda8a110db5d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6c3b6354346f48fd8f7bda8a110db5d2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6c3b6354346f48fd8f7bda8a110db5d22021-11-28T12:10:06ZPIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway10.1186/s10020-021-00410-31076-15511528-3658https://doaj.org/article/6c3b6354346f48fd8f7bda8a110db5d22021-11-01T00:00:00Zhttps://doi.org/10.1186/s10020-021-00410-3https://doaj.org/toc/1076-1551https://doaj.org/toc/1528-3658Abstract Background Alzheimer’s disease (AD), the most common form of dementia, is caused by the degeneration of the central nervous system (CNS). A previous study reported that signal transducer and activator of transcription 3 (STAT3) is activated during AD development; nonetheless, the related mechanism remains unknown. Thus, this study used a cell model to explore whether and how the protein inhibitor of activated STAT3 (PIAS3) is involved in AD development. Methods Cerebrospinal fluid (CSF) specimens of 30 patients with AD and 10 normal participants were included in this study. SH-SY5Y cells were used to constructed AD model. Relevant indices were then detected and analyzed. Results The results showed that compared with the control group, PIAS3 expression was substantially decreased in patients with AD and amyloid beta (Aβ)-treated SH-SY5Y cells. PIAS3 overexpression was able to reverse the detrimental effects of Aβ treatment on cell survival and growth. Further, it could also ameliorate apoptosis and oxidative stress in Aβ-treated SH-SY5Y cells. Additionally, PIAS3 was shown to reduce the activated form of STAT3 and increase the activity of the downstream Nestin/nuclear factor erythroid 2-related factor/heme oxygenase-1 pathway. Conclusions STAT3 reactivation by colivelin treatment negated the influence of PIAS3 on the survival, growth, apoptosis, and oxidative stress of Aβ-treated SH-SY5Y cells.Chen LiRuili WangYouyou ZhangChunting HuQiaoya MaBMCarticleAlzheimer’s diseaseAβPIAS3STAT3OxidativeApoptosisTherapeutics. PharmacologyRM1-950BiochemistryQD415-436ENMolecular Medicine, Vol 27, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Alzheimer’s disease Aβ PIAS3 STAT3 Oxidative Apoptosis Therapeutics. Pharmacology RM1-950 Biochemistry QD415-436 |
spellingShingle |
Alzheimer’s disease Aβ PIAS3 STAT3 Oxidative Apoptosis Therapeutics. Pharmacology RM1-950 Biochemistry QD415-436 Chen Li Ruili Wang Youyou Zhang Chunting Hu Qiaoya Ma PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway |
description |
Abstract Background Alzheimer’s disease (AD), the most common form of dementia, is caused by the degeneration of the central nervous system (CNS). A previous study reported that signal transducer and activator of transcription 3 (STAT3) is activated during AD development; nonetheless, the related mechanism remains unknown. Thus, this study used a cell model to explore whether and how the protein inhibitor of activated STAT3 (PIAS3) is involved in AD development. Methods Cerebrospinal fluid (CSF) specimens of 30 patients with AD and 10 normal participants were included in this study. SH-SY5Y cells were used to constructed AD model. Relevant indices were then detected and analyzed. Results The results showed that compared with the control group, PIAS3 expression was substantially decreased in patients with AD and amyloid beta (Aβ)-treated SH-SY5Y cells. PIAS3 overexpression was able to reverse the detrimental effects of Aβ treatment on cell survival and growth. Further, it could also ameliorate apoptosis and oxidative stress in Aβ-treated SH-SY5Y cells. Additionally, PIAS3 was shown to reduce the activated form of STAT3 and increase the activity of the downstream Nestin/nuclear factor erythroid 2-related factor/heme oxygenase-1 pathway. Conclusions STAT3 reactivation by colivelin treatment negated the influence of PIAS3 on the survival, growth, apoptosis, and oxidative stress of Aβ-treated SH-SY5Y cells. |
format |
article |
author |
Chen Li Ruili Wang Youyou Zhang Chunting Hu Qiaoya Ma |
author_facet |
Chen Li Ruili Wang Youyou Zhang Chunting Hu Qiaoya Ma |
author_sort |
Chen Li |
title |
PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway |
title_short |
PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway |
title_full |
PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway |
title_fullStr |
PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway |
title_full_unstemmed |
PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway |
title_sort |
pias3 suppresses damage in an alzheimer’s disease cell model by inducing the stat3-associated stat3/nestin/nrf2/ho-1 pathway |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/6c3b6354346f48fd8f7bda8a110db5d2 |
work_keys_str_mv |
AT chenli pias3suppressesdamageinanalzheimersdiseasecellmodelbyinducingthestat3associatedstat3nestinnrf2ho1pathway AT ruiliwang pias3suppressesdamageinanalzheimersdiseasecellmodelbyinducingthestat3associatedstat3nestinnrf2ho1pathway AT youyouzhang pias3suppressesdamageinanalzheimersdiseasecellmodelbyinducingthestat3associatedstat3nestinnrf2ho1pathway AT chuntinghu pias3suppressesdamageinanalzheimersdiseasecellmodelbyinducingthestat3associatedstat3nestinnrf2ho1pathway AT qiaoyama pias3suppressesdamageinanalzheimersdiseasecellmodelbyinducingthestat3associatedstat3nestinnrf2ho1pathway |
_version_ |
1718408145176363008 |